Aseptically Prepared Systemic Anti-Cancer Therapy Medicines
- Buyer
- Mid South Essex NHS Foundation Trust
- Published
- 2026-10-26
- Deadline
- Not provided
- Sources
- UK_FTS
- Value
- Not provided
Description
The description is in the source language.
This framework agreement is for the supply of a range of aseptically prepared, batch manufactured systemic anti-cancer therapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific systemic anti-cancer therapy drugs and medicines used in CIVAs.
Membership
Read notice previews free of charge. Official notice and document links, construction permits and personal MCP access require an active paid membership.
Read